FDA Unveils Risk Strategies For Drug Industry
The guidance was issued under the Food and Drug Administration Amendments Act of 2007, which gave the agency the authority to require the submission and implementation of a risk evaluation and mitigation strategy, or REMS, if it determines such a strategy is necessary to ensure that a drug’s benefits outweigh its risks.
Under the FDAAA,...
Already a subscriber? Click here to login